Authors
Loading...
Review highlights how genome-wide association studies inform management of cardiomyopathies, showing clinical utility of polygenic risk scores.
Dababneh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: